ID

37341

Description

Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02380521

Link

https://clinicaltrials.gov/show/NCT02380521

Keywords

  1. 7/18/19 7/18/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 18, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT02380521

Eligibility Type 2 Diabetes Mellitus NCT02380521

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. provision of informed consent prior to any study specific procedures;
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
2. men and women with t2dm aged >18 years;
Description

Diabetes Mellitus, Non-Insulin-Dependent | Age

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0001779
3. bmi >25 kg/m2;
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
4. hba1c 7.5-8.5 %;
Description

Hemoglobin A1c measurement

Data type

boolean

Alias
UMLS CUI [1]
C0474680
5. receiving metformin therapy (doses ranging from 1500 to 3000 mg daily) for at least 8 weeks.
Description

Metformin Dose U/day

Data type

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0456683
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. pregnancy or willingness to become pregnant;
Description

Pregnancy | Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
2. moderate and severe liver dysfunction;
Description

Liver Dysfunction Moderate | Liver Dysfunction Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0086565
UMLS CUI [1,2]
C0205081
UMLS CUI [2,1]
C0086565
UMLS CUI [2,2]
C0205082
3. moderate and severe renal failure;
Description

RENAL FAILURE MODERATE | Kidney Failure Severe

Data type

boolean

Alias
UMLS CUI [1]
C0748307
UMLS CUI [2,1]
C0035078
UMLS CUI [2,2]
C0205082
4. previous major cardiovascular event;
Description

Cardiovascular event Major

Data type

boolean

Alias
UMLS CUI [1,1]
C1320716
UMLS CUI [1,2]
C0205164
5. severe infections at the discretion of the investigator (such as human immunodeficiency virus [hiv], hepatitis b virus [hbv] and hepatitis c virus [hcv]);
Description

Communicable Diseases Severe | HIV Infection | Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0019693
UMLS CUI [3]
C0019163
UMLS CUI [4]
C0019196
6. any malignancy;
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
7. plasma triglycerides >400 mg/dl, plasma ldl-cholesterol > 250 mg/dl.
Description

Plasma triglyceride measurement | Plasma LDL cholesterol measurement

Data type

boolean

Alias
UMLS CUI [1]
C0583329
UMLS CUI [2]
C1278149

Similar models

Eligibility Type 2 Diabetes Mellitus NCT02380521

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. provision of informed consent prior to any study specific procedures;
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Age
Item
2. men and women with t2dm aged >18 years;
boolean
C0011860 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Body mass index
Item
3. bmi >25 kg/m2;
boolean
C1305855 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
4. hba1c 7.5-8.5 %;
boolean
C0474680 (UMLS CUI [1])
Metformin Dose U/day
Item
5. receiving metformin therapy (doses ranging from 1500 to 3000 mg daily) for at least 8 weeks.
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Pregnancy, Planned
Item
1. pregnancy or willingness to become pregnant;
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Liver Dysfunction Moderate | Liver Dysfunction Severe
Item
2. moderate and severe liver dysfunction;
boolean
C0086565 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0086565 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
RENAL FAILURE MODERATE | Kidney Failure Severe
Item
3. moderate and severe renal failure;
boolean
C0748307 (UMLS CUI [1])
C0035078 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Cardiovascular event Major
Item
4. previous major cardiovascular event;
boolean
C1320716 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
Communicable Diseases Severe | HIV Infection | Hepatitis B | Hepatitis C
Item
5. severe infections at the discretion of the investigator (such as human immunodeficiency virus [hiv], hepatitis b virus [hbv] and hepatitis c virus [hcv]);
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0019693 (UMLS CUI [2])
C0019163 (UMLS CUI [3])
C0019196 (UMLS CUI [4])
Malignant Neoplasms
Item
6. any malignancy;
boolean
C0006826 (UMLS CUI [1])
Plasma triglyceride measurement | Plasma LDL cholesterol measurement
Item
7. plasma triglycerides >400 mg/dl, plasma ldl-cholesterol > 250 mg/dl.
boolean
C0583329 (UMLS CUI [1])
C1278149 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial